Michael R. Hayden, Director at Xenon, holds 1.44M shares in AbCellera Biologics (Ticker: ABCL), holds 32.22K shares in Ionis Pharmaceuticals (Ticker: IONS), holds 142.44K shares in 89bio (Ticker: ETNB). Most recently, Michael R. Hayden Bought ― shares of AbCellera Biologics on Sep 26, 2023 for an estimated value of 98.20K.